UNCY — UNICYCIVE THERAPEUTICS INC
As of Q2 2026, 20 SEC-registered investment managers reported holding UNCY (UNICYCIVE THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $18.78M across 4.02M shares. That is +63.1% by share count (+1.56M shares) versus the previous quarter, while reported value moved +15.9%. Ownership is concentrated: the five largest holders account for 77.4% of reported value and the top ten for 94.6%.
Compared with the prior quarter, 9 opened new positions, 8 added to existing stakes, 3 trimmed, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
UNCY is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 1.41M | $6.63M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 788.59K | $4.55M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 564.02K | $2.65M | 0.00% | Add |
| Marshall Wace history | Q2 2026 | 547.86K | $2.57M | 0.00% | Add |
| Balyasny Asset Management history | Q1 2023 | 717.35K | $1.51M | 0.00% | New |
| Citadel Advisors history | Q2 2026 | 301.37K | $1.41M | 0.00% | Reduce |
| Millennium Management history | Q2 2026 | 271.46K | $1.27M | 0.00% | Reduce |
| Citigroup Inc history | Q2 2026 | 182.65K | $856.65K | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 181.93K | $853.25K | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 145.30K | $681.48K | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 109.64K | $514.24K | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 69.38K | $325.38K | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 54.84K | $257.21K | 0.00% | New |
| BNY Mellon history | Q2 2026 | 52.81K | $247.66K | 0.00% | New |
| Renaissance Technologies history | Q1 2026 | 24.40K | $160.55K | 0.00% | New |
| Bank of America Corp history | Q2 2026 | 31.64K | $148.38K | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 24.27K | $113.84K | 0.00% | New |
| Wells Fargo & Co history | Q2 2026 | 22.07K | $103.50K | 0.00% | New |
| JPMorgan Chase & Co history | Q2 2026 | 10.13K | $78.00K | 0.00% | New |
| Two Sigma Investments history | Q3 2021 | 25.55K | $72.00K | 0.00% | New |
New Positions (Q2 2026)
- Charles Schwab Investment Management 54.84K sh · $257.21K
- BNY Mellon 52.81K sh · $247.66K
- Deutsche Bank AG 24.27K sh · $113.84K
- Wells Fargo & Co 22.07K sh · $103.50K
- JPMorgan Chase & Co 10.13K sh · $78.00K
- Invesco Ltd 13.21K sh · $61.94K
- Legal & General Investment Management America 2.37K sh · $11.09K
- Fidelity Management & Research (FMR) 197 sh · $925
- T. Rowe Price Associates 20.05K sh · $95
Fully Exited (vs previous quarter)
- Renaissance Technologies sold 24.40K sh · $160.55K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | — | — | — | — | — | — | — | — | — | — | — | — | 71.82K | 72.27K | 83.24K | — | 36.35K | 36.35K | 35.90K | 1.41M |
| Geode Capital Management | 26.11K | 26.11K | 26.11K | 26.11K | 26.11K | 26.11K | 95.90K | 66.75K | 52.40K | 169.13K | 253.19K | 285.74K | 402.40K | 524.49K | 579.20K | 58.79K | 125.73K | 171.29K | 203.74K | 564.02K |
| Marshall Wace | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 154.94K | 547.86K |
| Citadel Advisors | — | — | 37.20K | 15.21K | — | — | — | — | — | 35.42K | 69.39K | — | — | — | — | — | 41.67K | 269.20K | 344.74K | 301.37K |
| Millennium Management | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1.01M | 1.40M | 271.46K |
| Citigroup Inc | — | — | — | — | — | — | — | — | — | — | — | — | — | 587 | — | — | 6.69K | 228 | 1 | 182.65K |
| Northern Trust Corp | — | — | — | — | — | — | — | — | — | — | 24.00K | 24.00K | 24.00K | 58.18K | 107.85K | 10.79K | 32.70K | 35.94K | 35.94K | 181.93K |
| Goldman Sachs Group | — | — | — | — | — | — | — | 95.93K | 93.23K | 93.34K | 93.34K | 93.35K | 93.42K | 73.61K | 73.47K | — | 45.20K | — | 27.09K | 145.30K |
| Morgan Stanley | — | 2 | — | — | — | — | — | — | — | — | — | — | — | 5.00K | 22.27K | 1.00K | 10.61K | 46.58K | 188.18K | 109.64K |
| UBS Group AG | 621 | 5.27K | — | 4.49K | 1.19K | — | — | 1.17K | 718 | 176 | 4.39K | 1 | 1 | 1 | 9.55K | — | 5.45K | 19.91K | 19.44K | 69.38K |
| Charles Schwab Investment Management | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 54.84K |
| BNY Mellon | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 52.81K |
| Bank of America Corp | — | 21 | — | — | — | 10 | — | — | — | — | — | 223 | 332 | 406 | 428 | 64 | 827 | 152 | 29.53K | 31.64K |
| Deutsche Bank AG | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 24.27K |
| Wells Fargo & Co | 32 | 32 | 33 | 36 | 45 | 46 | 47 | 49 | 39 | 193 | 196 | — | — | — | — | — | — | — | — | 22.07K |
| JPMorgan Chase & Co | — | — | — | — | — | — | — | — | — | — | 47 | 70 | 207 | 199 | 184 | 21.71K | — | — | — | 10.13K |
| Invesco Ltd | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 13.21K |
| Legal & General Investment Management America | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 2.37K |
| Fidelity Management & Research (FMR) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 197 |
| T. Rowe Price Associates | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 20.05K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details